The above two studies show that angioimmunoblastic T-cell lymphoma and anaplastic large-cell lymphoma (anaplastic lymphoma kinase-negative) showed better response rates and durable responses than other subtypes [57]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.